Sandwich, United Kingdom

Blanda L C Stammen

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2005-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Blanda L C Stammen. Retrieved from https://idiyas.com/inventor/blanda-l-c-stammen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Blanda L C Stammen: Innovator in Nicotinamide Derivatives

Introduction

Blanda L C Stammen is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on nicotinamide derivatives. With a total of 2 patents, Stammen's innovations are aimed at addressing various medical conditions.

Latest Patents

Stammen's latest patents focus on nicotinamide derivatives that are useful as PDE4 inhibitors. The inventions relate to the preparation of these derivatives, including the processes and intermediates involved. These nicotinamide derivatives are particularly beneficial in treating numerous diseases, disorders, and conditions, especially inflammatory, allergic, and respiratory issues, as well as wounds.

Career Highlights

Blanda L C Stammen is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Stammen has collaborated with notable coworkers, including Simon Bailey and Elisabeth C L Gautier. These partnerships have enhanced the scope and impact of his research.

Conclusion

Blanda L C Stammen is a distinguished inventor whose work on nicotinamide derivatives has the potential to significantly improve treatment options for various medical conditions. His contributions to Pfizer Corporation and the pharmaceutical field are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…